Disease

Carcinoma, Adenosquamous

Late-stage therapeutic developmentEmerging research

MeSHCarcinoma, Adenosquamous

Publications

Clinical trials

1999

Latest publication

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Research1999-05-01Journal of clinical oncology : official journal of the American Society of Clinical Oncology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme

All trials

Active

Late-stage

Completed

Late-stage studies

Randomized, Open Label, Phase III Trial Of CP- 751,871 In Combination With Paclitaxel And Carboplatin Versus Paclitaxel And Carboplatin In Patients With Non Small Cell Lung Cancer

Phase 3 · Terminated · Pfizer

Randomized, Open Label, Phase 3 Trial Of Erlotinib Alone Or In Combination With CP-751,871 In Patients With Advanced Non Small Cell Lung Cancer Of Non Adenocarcinoma Histology

Phase 3 · Terminated · Pfizer

Recently completed

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Phase 2 · Completed · University Health Network, Toronto

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1999 · 983 cites

Recent publications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1999 · 983 cites

Leading journals1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology1

Leading researchers8

Bundy BN1
Clarke-Pearson DL1
Fowler WC Jr1
Hannigan EV1
Liao SY1
Malfetano JH1
Sause W1
Whitney CW1

Affiliations (unnormalised)1

Thomas Jefferson University College of Medicine1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.

Identifiers

MeSHCarcinoma, Adenosquamous

References & data sources

Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
Related entities are derived from literature co-mention (studied together) — associative, not causal.